Zai Lab Announces Participation in November and December Investor Conferences

SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 18, 2024– Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2024:Goldman Sachs APAC Healthcare Corporate Day 2024 Time: November 5-8, 2024 Location: Hong Kong, Hong KongJefferies London Healthcare Conference Fireside Chat: Tuesday, November 19, 2024,2:30 p.m. GT Location: Aldwych, LondonCiti’s 2024 Global Healthcare Conference Time: December 3-5, 2024 Location: Miami, FloridaAbout Zai LabZai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.View source version on businesswire.com: https://www.businesswire.com/news/home/20241018377166/en/Investor Relations: Christine Chiou / Lina Zhang +1 (917) 886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.comMedia: Shaun Maccoun / Xiaoyu Chen +1 (415) 317-7255 / +86 185 0015 5011 shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.comSource: Zai Lab Limited